Yongji Co., Ltd.: The contract between TB and Medipharm labs has not been continued due to the adjustment of the other party's business model in Australia.


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login